7 Recruiting Myelodysplastic Syndromes Clinical Trials in Florida
Explore active myelodysplastic syndromes research studies enrolling across Florida. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Myelodysplastic Syndromes Studies in Florida
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
📍 Local Institution - 0137 — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
📍 Mayo Clinic — Jacksonville, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
📍 H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
📍 University of Miami — Miami, Florida
View Study & Checklist ➔